AxelaCare CON Approved for East Tennessee Region

Bass, Berry & Sims served as lead counsel to AxelaCare Health Solutions LLC – a subsidiary of United Health Group – in its efforts to obtain a Certificate of Need (CON) to initiate homecare operations in 34 counties in and around metropolitan Knoxville, Tennessee. The project received wide support – including from Wellmont Medical Associates – and was unanimously approved by state regulators. The addition of AxelaCare’s services in East Tennessee will make highly specialized immune globulin infusion therapy available at home to seriously ill patients suffering from very rare cancers and chronic immunological and neurological disorders. Researchers across the United States use data collected via AxelaCare’s proprietary patient care technology in a wide variety of clinical research.

AxelaCare specializes in specialty infusion therapy homecare services. Its nursing specialists have performed more than 44,000 infusion therapy sessions in recent years. AxelaCare has received the Joint Commission’s “Gold Seal” of approval and is recognized for meeting the highest clinical standards in the industry.

You Also May Be Interested In:

  • Representation of Bravo Wellness, a national provider of employee wellness solutions and portfolio company of ABS Capital, in its sale to Medical Mutual, a health insurance company based in Ohio

    We represented Bravo Wellness, an ABS Capital portfolio company, in its sale to Medical Mutual, a health insurance company based...
    Client Type: Private Company
  • Representation of MyHealthDirect, a digital care coordination platform, in its sale to Experian Health

    We represented MyHealthDirect, a provider of digital care coordination platform that optimizes scheduling for providers, payers and consumers, in its...
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company